Trial intelligence / Profile preview

Adderall XR and Strattera on Driving in ADHD Adults

NCT00557960Phase 3Completed

Sponsor
Takeda
Start
Feb 2004
Primary completion
Oct 2004
Modality
Small Molecules, Drug Delivery Systems
Countries
1
01

Overview

A Phase 3 trial of adderall xr, atomoxetine in attention deficit hyperactivity disorder (ADHD), sponsored by Takeda. Started Feb 2004; status: completed.

02

Drugs

adderall xratomoxetine
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT00557960.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00557960.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call